Adverse drug reactions profile of new drugs for Hepatits C (2016)
Fonte: Brazilian Journal of Pharmaceutical Sciences. Nome do evento: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assuntos: HEPATITE C, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KOHATSU, Denise Yukari e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Adverse drug reactions profile of new drugs for Hepatits C. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2016APA
Kohatsu, D. Y., Ribeiro, A. G., & Kano, E. K. (2016). Adverse drug reactions profile of new drugs for Hepatits C. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Kohatsu DY, Ribeiro AG, Kano EK. Adverse drug reactions profile of new drugs for Hepatits C. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 27 res. FCF050.[citado 2024 nov. 04 ]Vancouver
Kohatsu DY, Ribeiro AG, Kano EK. Adverse drug reactions profile of new drugs for Hepatits C. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 27 res. FCF050.[citado 2024 nov. 04 ]
